Skip to main content

Apellis Pharmaceuticals Inc(APLS-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Apellis Pharmaceuticals Inc

100 FIFTH AVENUE
WALTHAM MA 02451 USA
P: 617-977-5700
http://www.apellis.com

Profile

Apellis Pharmaceuticals, Inc. is a clinical-stage biotech focused on the development of novel therapeutics, which work through the inhibition of the complement system, specially targeting the C3 protein of the complement system to treat autoimmune and inflammatory diseases.

Key Executives

NameTitle
Information not available.

More from The Globe

Small-cap stocks to watch: Poet Technologies, Aurora Cannabis, AGF, Chemtrade, Savaria and more
FILE PHOTO: People walk through the Canary Wharf financial district of London, Britain, December 7, 2018. REUTERS/Simon Dawson/File Photo
ASML lifts 2026 forecast as surging AI chip demand boosts new orders
FILE PHOTO: The ASML logo is seen at the company's headquarters in Veldhoven, Netherlands, June 16, 2023. REUTERS/Piroschka van de Wouw/File Photo
The most oversold and overbought stocks on the TSX
A red light on Bay Street in Canada's financial district is shown in Toronto on Wednesday, March 18, 2020.
Monday’s analyst upgrades and downgrades
Quebecor headquarters in Montreal in March of 2023.
Bullish on BorgWarner Inc.
Monica Rizk
Nine of 10 Vizsla Silver workers confirmed dead after January abductions in Mexico
The sisters of miner Jose Angel Hernandez, who was found dead, embrace as they take part in a march with miners and relatives of missing workers demanding justice for workers who were abducted from a mine operated by Canada's Vizsla Silver Corp., after several bodies were found last month in a clandestine grave in Concordia, Sinaloa, in Zacatecas, Mexico, February 14, 2026. REUTERS/Edgar Chavez
Bullish potential on Tyson Foods Inc.
Monica Rizk
Quebecor’s Freedom Mobile is enjoying a newfound status
Pierre Karl Peladeau, CEO of Quebecor Inc. at the Freedom Mobile store at 88 Queens Quay West in Toronto, on April 1, 2026. (Fred Lum/The Globe and Mail)

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.